MDXG · Mimedx Group, Inc.
10 customers — 22% of revenue (the year ended December 31, 2025)
“For the years ended December 31, 2025, 2024, and 2023, our top ten customers accounted for 22%, 20% and 20%, respectively, of our net sales”
Key customers — 1% of revenue (the year ended December 31, 2025)
“net sales to all U.S. government accounts comprised approximately 1%, 1% and 2%, respectively, of our net sales.”
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
| Program Announced | Authorized | Remaining | As of | Runs Through | Source |
|---|---|---|---|---|---|
| 2026-02-25 | $100,000,000 | — | — | — | 8-K , filed 2026-02-25 |
Cash spent on buybacks by quarter
Cash deployed each quarter. Δ marks quarters derived from the company's cumulative year-to-date disclosures.
Repurchase History
| Fiscal Year Ended | Cash Spent | Source |
|---|---|---|
| 2026-06-30 YTD | $12,468,000 | 10-Q, filed 2026-07-29 |
| 2025-12-31 | $0 | 10-K, filed 2026-02-25 |
| 2024-12-31 | $0 | 10-K, filed 2026-02-25 |
| 2023-12-31 | $9,515,000 | 10-K, filed 2026-02-25 |
| 2022-12-31 | $0 | 10-K, filed 2025-02-26 |
| 2021-12-31 | $0 | 10-K, filed 2024-02-28 |
| 2020-12-31 | $900,000 | 10-K, filed 2021-03-08 |
| 2018-12-31 | $7,600,000 | 10-K, filed 2021-03-08 |
| 2017-12-31 | $68,300,000 | 10-K, filed 2020-07-06 |
| 2016-12-31 | $10,400,000 | 10-K, filed 2020-03-17 |
| 2015-12-31 | $40,143,000 | 10-K, filed 2017-02-22 |